| abstract |
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by structural formula (XXIV) or Z-Y-(CH2)n-X-NR50R5 and physiologically acceptable salts thereof. |